Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
adapt, adapted, agenda, AIN, Aircraft, Albany, AMGEVITA, AMJEVITA, anti, antigen, arose, art, assay, Authorisation, autoimmune, baseload, batch, bemarituzumab, beneficiary, biennial, binding, booster, cargo, Carolina, catastrophic, CCPA, CEO, CIT, climate, Commissioner, convened, Cosentyx, crowded, Daiichi, decade, dedicated, deepen, degradation, delta, developmental, discarded, distinguish, domain, DoR, easily, Efavaleukin, Enrichment, erosion, ESG, Ethical, exploiting, FASPRO, fellowship, firmly, flat, fluoropyrimidine, FOMBPR, friendly, FTC, GEJ, gradual, guard, hand, headquartered, HeFH, hesitancy, highlighting, HLE, HoFH, Holly, Howard, ID, ILA, inflationary, intentionally, invisible, ishrak, ITP, journey, Juan, Khosla, KKC, Kyowa, lab, Lazard, leucovorin, link, Longshoremen, malfunctioned, maritime, mCRPC, Merger, merit, modality, multispecific, mutein, nasal, Neumora, oldest, omar, omicron, orderly, Ordesekimab, overexpressing, overrun, oxaliplatin, paired, palmoplantar, PDUFA, persistent, Ph, phaseout, poll, port, Prime, promptly, Rachna, reconciliation, redesign, redesigning, reliant, repeated, Rescue, RIABNI, robust, Salomon, Sankyo, scheme, Skyrizi, SOFR, splenectomy, strike, substance, Suisse, suppressed, Taltz, tangibly, Tarlatamab, Teneobio, TEZSPIRE, TNF, Tremfya, tropical, Tuxedo, ulcerative, underrepresented, unexpired, unreliability, upward, Urban, urticaria, variant, viable, Virginia, visible, Win, WISE, withdrew, worth, Zone
Removed:
activator, adalimumab, administering, Ajanta, AMGEVITATM, AMJEVITATM, Amsterdam, array, assert, bench, bevacizumab, billing, blueprint, Breckenridge, Cadila, Calcium, carcinoma, cardiovascular, children, cholesterol, comparability, compute, computed, computing, Consulting, convertase, Corlanor, Cosmetic, counterclaimed, curve, declaration, differentiated, disclose, dismissing, disposable, Dissolution, Eli, ErelziTM, ESRD, familial, forma, FZE, heard, horizon, humanized, hypercholesterolemia, ideation, immunotherapy, inequitable, infliximab, innopharma, Inspector, iodine, ivabradine, Johnson, keytruda, kidney, laherparepvec, Lastly, leasing, lieu, lipoprotein, liver, lymphoma, MAA, mecarbil, Medicinal, melanoma, Micro, mortgage, narrowing, Nexavar, NIVESTYMTM, omecamtiv, oncolytic, parent, pembrolizumab, percent, Piacquad, pilot, Piramal, plc, POMALYST, post, preacquisition, preexisting, prepayment, Pro, proprotein, pte, Qilu, radioactive, recording, Reddy, registrational, relieved, remeasure, remission, replacing, responding, retrofitting, revalued, rituximab, Sagent, simplex, solicited, stop, suicidal, Sun, talimogene, Thrombopoietic, thyroid, translating, transplantation, trastuzumab, twelve, UK, unaudited, unclean, underway, undisclosed, unenforceability, vacate, vigorously, Zarxio
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view